Poll: Should Hydrocodone Combination Products Change to Schedule II?

The Drug Enforcement Administration (DEA) published a proposal to reschedule hydrocodone combination products (HCPs) from Schedule III to Schedule II. This is a proposal recommended by the Assistant Secretary for Health and supported by the DEA's data evaluation.In your opinion, should hydrocodone combination products change to Schedule II?